PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES
The present invention relates to a pharmaceutical composition for use in the treatment of diabetes, containing metformin and teneligliptin. The pharmaceutical composition for use in the treatment of diabetes according to the present invention can cut off the contact between the teneligliptin and met...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to a pharmaceutical composition for use in the treatment of diabetes, containing metformin and teneligliptin. The pharmaceutical composition for use in the treatment of diabetes according to the present invention can cut off the contact between the teneligliptin and metformin, so that the lifespan of the composition is increased and the amount as well as the kind of impurities contained in the composition is reduced. Furthermore, the teneligliptin can be rapidly released and the sustained-release of metformin can be controlled. The present invention relates to a pharmaceutical composition for treating diabetes, containing metformin and a DPP-TV inhibitor. The pharmaceutical composition for treating diabetes according to the present invention can cut off the contact between the DPP-TV inhibitor and metformin, so that the lifespan of the composition is increased and the amount as well as the kind of impurities contained in the composition is reduced. Furthermore, the DPP-TV inhibitor can be rapidly released and the sustained-release of metformin can be controlled. [Accompanying Fig. 1] |
---|